• BiotechnologyModern biological science
  • Human PurposeModifying living organisms
  • MeetingsTechnical advances
  • MeetingsKnowledge Sharing
  • MeetingsMalaria Studies
Biotechnology1 Human Purpose2 Meetings3 Media Training4 Media Training5
Carousel CSS3 by v4.2
You are here:  HomeDr. Thomas G. Egwang, (Uganda)

Dr. Egwang  has professional degrees in veterinary medicine (BVM, Uganda),  parasitology (MS, Canada), immunology  (PhD, Canada) between 1973-1983; on top of this, he trained in business administration (MBA, Tanzania/Netherlands) during 2007-2009 .

He undertook postdoctoral training in molecular biology in the USA at Case Western Reserve University, Cleveland, OH and University of California in Berkeley, CA from 1984 to 1987. He joined the Centre Internationale des Recherches Medicale du Franceville (CIRMF, Gabon) in 1987 where he established a molecular parasitology laboratory from scratch.  His research provided critical insights about the immunology and diagnosis of loaisis and a nicotinic acetylcholine receptor subunit of Onchocerca volvulus was cloned for the first time.

Upon return to Uganda in 1995 he co-founded Med Biotech Laboratories (MBL) which has became a major player in malaria research and contributed significantly to the development of the blood stage vaccine BK-SE36 vaccine. He was Executive Director of the African Academy of Sciences (Kenya) from 2008 to 2009.

In Gabon, Kenya, and Uganda, he has mentored young scientists and investigators who are now research leaders in Africa and beyond. He has served on national, regional, and international scientific panels of the World Health Organization, EU, European and African Countries Clinical Trials Partnership (EDCTP), the consortium for National Health Research (CNHR), amongst others.

He served as Academic  Editor  PLoS Biology, and received several national and international awards including a Career Development Grant from the WHO/TDR, an International Leadership Award, and an International Research Scholar of the Howard Hughes Medical Institute (HHMI). Dr. Egwang’s research activities has spanned the whole gamut from malaria immuno-epidemiological studies, malaria in pregnancy, antimalarial drug resistance, malaria vaccine studies, and community-driven mosquito vector control to bio-prospecting for natural products